phosphine has been researched along with Cancer of Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azmanova, M; Cooper, PA; Pitto-Barry, A; Rafols, L; Seaton, CC; Shnyder, SD | 1 |
| Abu El Maaty, MA; Aguiló, E; Andermark, V; Bunjes, H; Che, CM; Göke, K; Kokoschka, M; Lum, CT; Oehninger, L; Ott, I; Rodríguez, L; Sun, RW; Wölfl, S; Zou, T | 1 |
| Anjum, R; Cai, L; Clackson, T; Dalgarno, D; Dodd, R; Dwight, TA; Huang, WS; Jang, HG; Keats, J; Kohlmann, A; Li, F; Liu, S; Lu, X; Mohemmad, QK; Moran, LE; Narasimhan, NI; Ning, Y; Parillon, L; Qi, J; Rivera, VM; Romero, J; Shakespeare, WC; Thomas, M; Toms, A; Wang, F; Wang, Y; Wardwell, SD; Xu, Q; Xu, R; Xu, Y; Zhang, S; Zhou, T; Zhu, X; Zou, D | 1 |
| Bindoli, A; Björnstedt, M; Brodin, D; Brodin, O; Fernandes, AP; Flygare, J; Gandin, V; Hedman, M; Marzano, C; Rigobello, MP; Selenius, M | 1 |
4 other study(ies) available for phosphine and Cancer of Lung
| Article | Year |
|---|---|
Anticancer Water-Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Female; Humans; Ligands; Lung Neoplasms; Organophosphorus Compounds; Ovarian Neoplasms; Phosphines; Reactive Oxygen Species; Ruthenium; Water | 2022 |
Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.
Topics: Animals; Anisoles; Antineoplastic Agents; Cations, Monovalent; Cell Proliferation; Cell Survival; Coordination Complexes; Female; Gold; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HT29 Cells; Humans; Ligands; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Chaperones; Organogold Compounds; Phosphines; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase; Xenograft Model Antitumor Assays | 2016 |
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase.
Topics: Administration, Oral; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Mice; Mice, SCID; Molecular Conformation; Neoplasms, Experimental; Organophosphorus Compounds; Phosphines; Protein Kinase Inhibitors; Pyrimidines; Rats; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship | 2016 |
Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression.
Topics: Blotting, Western; Cell Cycle; Cell Line; Gold Compounds; Humans; Lung Neoplasms; Oxidation-Reduction; Phosphines; Radiation Tolerance; Radiation, Ionizing; RNA, Small Interfering; Thioredoxin-Disulfide Reductase; Up-Regulation | 2012 |